Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ p14ARF/CDKN2A Antibody Blocking Peptide
Click to view available options
Quantity:
0.1 mg
Specifications
Specifications
| Gene ID (Entrez) | 1029 |
| Concentration | 1 mg/mL |
| Content And Storage | Store at -80°C. Avoid freeze/thaw cycles. |
| For Use With (Application) | This Peptide is Useful as a Blocking Peptide for NB200-111 |
| Gene Alias | ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2 A, cyclin-dependent kinase inhibitor 2 A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, p16, p16-INK4, p16INK4a, p16-INK4a, P19, p19ARF, TP16 |
| Gene Symbol | CDKN2A |
| Quantity | 0.1 mg |
| Research Category | ABC Transporters, Biologically Active Proteins, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, p53 Pathway, Transcription Factors and Regulators, Tumor Suppressors |
| Storage Buffer | Peptide dissolved in dH20. Contains no BSA. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction